OPTIMIZATION OF RECOMBINANT ANTIBODY PRODUCTION IN CHO CELLS

The optimization of recombinant antibody production from Chinese hamster ovary (CHO) cells remains a paramount challenge with the biopharmaceutical industry. Multiple strategies have been employed maximize antibody titer, such as process parameter optimization, media optimization, and implementation of perfusion technologies. Fine-tuning media co